Clinical Trials Logo

Lymphedema of Upper Arm clinical trials

View clinical trials related to Lymphedema of Upper Arm.

Filter by:

NCT ID: NCT04690439 Recruiting - Breast Cancer Clinical Trials

Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema

LymphLight
Start date: February 22, 2021
Phase: N/A
Study type: Interventional

Up to one out of five patients with breast cancer will develop lymphedema in the upper extremity after cancer treatment. Patients with breast cancer-related lymphedema (BCRL) suffer from pain, heaviness, tightness, and a decreased range of motion. Photobiomodulation therapy (PBMT) is a non-invasive therapy based on the application of visible and/or near-infrared light produced by a laser diode or a light-emitting diode. The scientifically proven biologic effects of PBM are improved wound healing, and a reduction in pain, inflammation, and oedema. Therefore, the aim of this study is to evaluate the effectiveness of PBMT on the management of BCRL.

NCT ID: NCT04659564 Completed - Quality of Life Clinical Trials

Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study

DAYSPRING
Start date: August 5, 2020
Phase: N/A
Study type: Interventional

An open-label study to clinically assess a novel wearable advanced compression technology (Dayspring™) undertaken to determine if potential barriers to lymphedema self-care were effectively addressed. The Dayspring™ device is a novel FDA-cleared wearable solution that is portable and easy-to-use sequential compression system. The following endpoints are examined: 1. Improvement in QoL in subject with upper-extremity edema after 28 days as measured by the LYMQOL disease-specific validated assessment tool. 2. Arm volume maintenance or improvement as measured prior to and after 28 days of device use. 3. Safety as assessed by reported adverse events 4. Patient satisfaction as measured by visual analog scale (VAS) and survey at the end of the study; and 5. Adherence to therapy as measured with a smart phone app.

NCT ID: NCT04570722 Completed - Breast Cancer Clinical Trials

Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)

iPIVAP
Start date: September 20, 2021
Phase: N/A
Study type: Interventional

This pilot study will examine facilitators and barriers that impact staff uptake for implementation of practice change involving ipsilateral IV insertion in patients with axillary lymphadenectomy/dissection in a single radiology center.

NCT ID: NCT04435639 Not yet recruiting - Clinical trials for Lymphedema of Upper Arm

Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema

Start date: October 30, 2020
Phase: N/A
Study type: Interventional

This is a pilot randomised controlled trial investigating the use of an adjustable compression garment in the treatment of patients with Breast Cancer related upper limb Lymphoedema. This study will be conducted as part of a MSc qualification at the Institute of Technology Sligo in Ireland with all therapy sessions taking place in the Physiotherapy Department of Sligo University Hospital (formerly Sligo General Hospital). The study will be conducted in conjunction with Sligo University Hospital and it has attained ethical approval through the relevant University Hospital Ethics Committee.

NCT ID: NCT04296929 Recruiting - Breast Cancer Clinical Trials

The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema.

Start date: November 28, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to determine the effect of complex decongestive physiotherapy in women with unilateral breast cancer-related lymphedema on sensory parameters.

NCT ID: NCT04246034 Withdrawn - Lymphedema Clinical Trials

Microvascular Breast Reconstruction With Lymph Node Transfer

Start date: January 2021
Phase: N/A
Study type: Interventional

this study aims to evaluate the outcomes of simultaneous free abdominal flap & vascularized lymph node transfer for both breast reconstruction and postmastectomy lymphedema

NCT ID: NCT04213001 Completed - Clinical trials for Lymphedema of Upper Arm

Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema

Start date: January 2, 2020
Phase: N/A
Study type: Interventional

Breast cancer is the most common cancer in women. It is an important health problem that has been increasingly encountered in recent years. With advances in treatment, the survival time after breast cancer is prolonged, and as a result, many women face certain diseases during this period. One of these diseases, breast cancer-related lymphedema, is characterized by abnormal accumulation of protein-rich fluid in the interstitial tissue, which can occur at any time after breast cancer surgery or radiotherapy and is a major cause of morbidity.Early and accurate diagnosis of lymphedema is very important for effective treatment. In routine clinical practice there are various methods used to diagnose lymphedema such as history, physical examination and limb circumference. Circumferential measurement is based on the principle of circumference measurement at certain intervals (such as 4 cm, 5 cm, 10 cm) from certain anatomical reference points on the extremities. Volume calculation can also be made from a data obtained from circumferential measurements via a computer program. Circumferential and volume measurements are used in the diagnosis, severity of lymphedema and follow-up of treatment. Although it is the most commonly used method in practice, circumferential measurements and volume measurements alone can ignore changes in tissue structure and significant changes in the presence of latent lymphedema. At the same time, circumferential measurements are made at regular intervals and the difference between the healthy side and 2 cm or more is considered as lymphedema, which may neglect tissue and edema changes in areas not in the measuring area. Ultrasonography, which has been used in the measurement and evaluation of lymphedema in recent years, is a noninvasive economic method. Skin and subcutaneous distance in lymphedema can be measured by ultrasonography, and changes in tissue structure, fibrous tissue, adipose tissue and muscle tissue can be demonstrated. Fibrotic changes in lymphedema tissue play a key role in progression. Subcutaneous ultrasound echogenicity (SEG), which is thought to be a measure of lymphedema severity in extremities, was determined as stages 0, 1 and 2. According to this; Stage 0: No increase in echogenicity in the subcutaneous layer. That is, the subcutaneous fat layer is observed as black. Stage 1: Diffuse increase in echogenicity, but identifiable horizontal or oblique-focused echogenic lines caused by bundles of connective tissue may be seen. In this study, the investigators aimed to determine the correlation between circumferential measurements and skin and subcutaneous tissue ultrasonography in breast cancer-related lymphedema patients.The primer aim of this study is to investigate the correlation between circumferential measurements and ultrasonographic measurements in breast cancer-related lymphedema. The secondary aim is to investigate the relationship among the changes in subcutaneous tissue structure (subcutaneous ultrasound echogenicity degree-SEG) and lymphedema severity in breast cancer-related lymphedema.

NCT ID: NCT04203069 Recruiting - Clinical trials for Lymphedema of Upper Arm

Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase

LYMphoNIGHT
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

This study aims to assess Auto-Adjustable MOBIDERM® Autofit Armsleeve effect on upper limb volume excess after 3 months of maintenance phase treatment in patients with secondary upper limb lymphedema following breast cancer. Half of the patient will wear a day-time and night time compression garment (MOBIDERM Autofit) for 3 months during the maintenance phase, while the other half will only wear day-time compression garment.

NCT ID: NCT04139291 Not yet recruiting - Clinical trials for Lymphedema of Upper Arm

Ultrasonographic Evaluation of Changes After Complex Decongestive Therapy

Start date: October 20, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate tissue changes via ultrasound after complex decongestive therapy.

NCT ID: NCT04138667 Recruiting - Clinical trials for Lymphedema of Upper Arm

Responsiveness of Outcome Scales in Breast Cancer Related Lymphedema

Start date: October 19, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to investigate and compare responsiveness of current lymphedema assessment scales validated in Turkish.